跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,951 条关于
“LRRK2 inhibitor”
全部
19,951
临床试验
9,796
药物
4,067
机构
21
资讯
6,067
去年
Montara Therapeutics Receives $3.3M Grant from Michael J. Fox Foundation to Develop Brain-Selective LRRK2 Inhibitor for Parkinson's
去年
Halia Therapeutics Doses First Healthy Volunteer with Oral LRRK2 Inhibitor HT-4253 for Alzheimer's
去年
Halia Therapeutics Presents LRRK2 Inhibitor HT-4253 for Neurodegenerative Diseases at BIO Investor Forum
8个月前
Brenig Therapeutics Initiates First-in-Human Trial of Brain-Selective NLRP3 Inhibitor BT-409 for Neurodegenerative Diseases
去年
Denali Therapeutics Initiates Phase 2a Trial of BIIB122 for LRRK2-Associated Parkinson's Disease
昨天
SK Biopharmaceuticals Licenses Preclinical LRRK2/c-Abl Dual Inhibitor 1ST-104 for Parkinson's in Deal Worth Up to $314.8M
去年
Brenig Therapeutics Initiates Phase 1 Trial of BT-267 for Parkinson's Disease
去年
Neuron23 Secures $96.5M Series D Funding as First Patient Dosed in Phase 2 Parkinson's Disease Trial
去年
Brenig Therapeutics Appoints New Leadership and Expands Parkinson's Disease Pipeline with NLRP3 Inhibitor Acquisition
5个月前
Biognosys Partners with Michael J. Fox Foundation to Develop Critical LRRK2 Biomarker Assays for Parkinson's Disease
第 1 页,共 607 页
上一页
下一页